U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
190801190801Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma MultiformeCompletedHas ResultsGlioblastoma MultiformeDrug: Temozolomide|Drug: R115777https://ClinicalTrials.gov/show/NCT00050986
190802190802Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung CancerCompletedNo Results AvailableNon-small Cell Lung CancerDrug: bexarotenehttps://ClinicalTrials.gov/show/NCT00050973
190803190803Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung CancerCompletedHas ResultsNon-small Cell Lung CancerDrug: bexarotene with carboplatin and paclitaxel|Drug: carboplatin and paclitaxelhttps://ClinicalTrials.gov/show/NCT00050960
190804190804Pediatric Epilepsy StudyCompletedNo Results AvailableEpilepsyDrug: oxcarbazepinehttps://ClinicalTrials.gov/show/NCT00050947
190805190805Pediatric Epilepsy StudyCompletedNo Results AvailableEpilepsy|Epilepsies, PartialDrug: oxcarbazepinehttps://ClinicalTrials.gov/show/NCT00050934
190806190806Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV DrugsCompletedNo Results AvailableHIV InfectionsDrug: somatropin|Biological: Hepatitis A virus, inactivated|Drug: Keyhole-Limpet Hemocyaninhttps://ClinicalTrials.gov/show/NCT00050921
190807190807Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV DrugsCompletedNo Results AvailableHIV Infectionshttps://ClinicalTrials.gov/show/NCT00050908
190808190808Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive PatientsCompletedNo Results AvailableHIV InfectionsDrug: Lopinavir/ritonavir|Drug: Efavirenz|Drug: Stavudine|Drug: Zidovudine|Drug: Lamivudine|Drug: Tenofovir disoproxil fumaratehttps://ClinicalTrials.gov/show/NCT00050895
190809190809Safety and Effectiveness of an Investigational Agent (GM-611) in Patients With Diabetic GastroparesisCompletedNo Results AvailableGastroparesisDrug: GM-611https://ClinicalTrials.gov/show/NCT00050882
190810190810Learning a Motor Task Through ObservationCompletedNo Results AvailableHealthyhttps://ClinicalTrials.gov/show/NCT00050869
190811190811Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 InfectionCompletedNo Results AvailableHIV InfectionsDrug: Enfuvirtide T/20/Ro 29,9800, HIV-1 Infusion Inhibitorhttps://ClinicalTrials.gov/show/NCT00050856
190812190812A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic SyndromesCompletedNo Results AvailableMyelodysplastic SyndromesDrug: thalidomidehttps://ClinicalTrials.gov/show/NCT00050843
190813190813A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung CancerCompletedNo Results AvailableLung NeoplasmsDrug: CI 1033https://ClinicalTrials.gov/show/NCT00050830
190814190814Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)CompletedNo Results AvailableArteriosclerosisDrug: clopidogrel (SR25990)https://ClinicalTrials.gov/show/NCT00050817
190815190815Evaluation of Stress DisordersCompletedNo Results AvailableAcute Traumatic Stress Disorders|Post-Traumatic Stress DisordersDrug: sertralinehttps://ClinicalTrials.gov/show/NCT00050804
190816190816Effects of Leptin Treatment on Weight LossCompletedNo Results AvailableObesityDrug: Leptin|Behavioral: Very Low Calorie Diethttps://ClinicalTrials.gov/show/NCT00050791
190817190817A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple SclerosisCompletedHas ResultsMultiple Sclerosis, Relapsing-RemittingBiological: Interferon beta-1a|Biological: Alemtuzumab 12 mg|Biological: Alemtuzumab 24 mghttps://ClinicalTrials.gov/show/NCT00050778
190818190818Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial InjectionNot yet recruitingNo Results AvailableCongestive Heart Failure|Coronary Artery Disease|Myocardial InfarctionDrug: MyoCellâ„¢ Autologous Myoblastshttps://ClinicalTrials.gov/show/NCT00050765
190819190819Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal CancerRecruitingNo Results AvailableRenal Tumor Histology|Cutaneous Leiomyomatosis|Kidney Cancerhttps://ClinicalTrials.gov/show/NCT00050752
190820190820Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2CompletedNo Results AvailableHIV InfectionsDrug: Interleukin-2https://ClinicalTrials.gov/show/NCT00050726
190821190821Sirolimus Therapy for Idiopathic and Lupus Membranous NephropathyCompletedNo Results AvailableMembranous Glomerulonephritis|Lupus Membranous NepropathyDrug: Sirolimushttps://ClinicalTrials.gov/show/NCT00050713
190822190822Brain Imaging in DepressionCompletedNo Results AvailableDepression|Bipolar Disorderhttps://ClinicalTrials.gov/show/NCT00050700
190823190823Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory MalignanciesTerminatedNo Results AvailableProstatic Neoplasms|Multiple Myeloma|Bladder Neoplasms|LymphomaDrug: Gallium maltolatehttps://ClinicalTrials.gov/show/NCT00050687
190824190824Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung CarcinomaCompletedNo Results AvailableNon-small Cell Lung CancerDrug: Filgrastim-SD/01https://ClinicalTrials.gov/show/NCT00050674
190825190825To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis VulgarisCompletedNo Results AvailablePsoriasisDrug: Daclizumab|Device: NB-UVBhttps://ClinicalTrials.gov/show/NCT00050661
190826190826To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis VulgarisCompletedNo Results AvailablePsoriasisDrug: Daclizumab|Drug: Cyclosporine|Drug: cyclosporine and Daclizumabhttps://ClinicalTrials.gov/show/NCT00050648
190827190827STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced DiarrheaCompletedNo Results AvailableNeoplasms|DiarrheaDrug: Sandostatin LAR Depothttps://ClinicalTrials.gov/show/NCT00050635
190828190828Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)CompletedNo Results AvailableAttention Deficit Disorder With HyperactivityDrug: Methylphenidate|Behavioral: Comprehensive behavioral treatment programhttps://ClinicalTrials.gov/show/NCT00050622
190829190829Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach EmptyingCompletedNo Results AvailableGastroparesisDrug: tadalafil|Drug: tadalafil|Drug: placebohttps://ClinicalTrials.gov/show/NCT00050609
190830190830Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate CancerCompletedNo Results AvailableProstate CancerDrug: MDX-010 / MDX-010 + Docetaxelhttps://ClinicalTrials.gov/show/NCT00050596

* Görseller ve İçerik tekif hakkına sahip olabilir